Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CO-MIDIS TABLETS 80MG/5MG - HSA Drug Approval Details

Approvals/HSA/CO-MIDIS TABLETS 80MG/5MG

Approved

THERAPEUTIC

CO-MIDIS TABLETS 80MG/5MG

Standard Chem. & Pharm. Co. Ltd.🇸🇬 Health Sciences Authority

Approval Date: Nov 24, 2022
Approval ID: f1f3472b9c44123a
Company: Standard Chem. & Pharm. Co. Ltd.
Type: Therapeutic

Approval Details

Approval Id: f1f3472b9c44123a
Drug Name: CO-MIDIS TABLETS 80MG/5MG
Product Name: CO-MIDIS TABLETS 80MG/5MG
Approval Number: SIN16647P
Approval Date: 2022-11-24
Registrant: NOVEM HEALTHCARE PTE LTD
Licence Holder: NOVEM HEALTHCARE PTE LTD
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: C09DB04
Atc Item Name: telmisartan and amlodipine
Pharma Manufacturer Name: NOVEM HEALTHCARE PTE LTD
Company Detail Path: /organization/3defe21a39b9ebea/novem-healthcare-pte-ltd

Active Ingredients

Telmisartan

80 mg

Amlodipine besylate eqv Amlodipine

5 mg

AMLODIPINE BESYLATE EQV AMLODIPINE

5 MG

TELMISARTAN

80 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Nov 24, 2022

Approval ID

f1f3472b9c44123a

Type

Therapeutic

Back to HSA Approvals